Know what the FDA thinks

Instantly answer regulatory questions with up to 1,000 documents from public health authority databases without hallucinations.

A research product built for Regulatory Affairs

26 regulatory and clinical databases across 6 markets

What kinds of mouthwashes have been approved by the FDA / EMA and which regulatory pathways have they taken?

Answer

Based on the provided FDA and EMA datasets, the following summarizes the types of mouthwashes approved and the regulatory pathways they have taken:


1. Mouthwashes Approved as Medical Devices (FDA 510(k) Pathway)

These products are typically classified as medical devices and are cleared via the FDA's 510(k) premarket notification process. They are often "substantially equivalent" to predicate devices already on the market.

A. Dry Mouth Relief / Artificial Saliva Mouthwashes

  • Examples:
    • Biotene Dry Mouth Oral Rinse 2241939
    • Oral-B Dry Mouth Oral Rinse 59505672
    • SmartMouth DryMouth Oral Rinse 73454
    • TheraBreath Dry Mouth Oral Rinse 11123361
    • Oral7 Moisturizing Mouthwash 6465962
    • GuruNanda Dry Mouth Oral Rinse 31
    • Hydris Oral Rinse 28294078
    • GUM HYDRAL Dry Mouth Oral Rinse 14
    • Moisyn Dry Mouth Oral Rinse 1558
    • Dr. Fresh Dry Mouth Mouthwash 11730
  • Regulatory Pathway: FDA 510(k) clearance as "saliva, artificial" (Product Code: LFD), typically unclassified or Class II medical devices. These products are reviewed for substantial equivalence to predicate devices and are subject to general controls (registration, labeling, GMP, etc.) 22457111415283134465056586272.

B. Desensitizing Mouthwashes

  • Examples:
    • Colgate Desensitizing Mouthwash / Sensitive Pro-Relief 82341
    • LISTERINE Sensitivity Defense Mouthrinse 33651
  • Regulatory Pathway: FDA 510(k) clearance, typically as "cavity varnish" (21 CFR 872.3260, Product Code: LBH), Class II devices. These are cleared based on substantial equivalence to predicate devices for the management of sensitive teeth 3823364151.

C. Oral Wound and Mucositis/Stomatitis Rinses

  • Examples:
    • Aftamed Mouthwash 4162126
    • MuGard Mucoadhesive Oral Wound Rinse 42
    • OraMagicRx Oral Wound Rinse 27
    • OraMagic Plus Oral Wound Rinse 74
  • Regulatory Pathway: FDA 510(k) clearance, often as "hydrogel wound dressing" or "mucositis/stomatitis oral rinse" (Product Code: MGQ), unclassified or Class II devices 4162126274274.

D. Plaque/Gingivitis Reduction Rinses (Non-drug)

  • Examples:
    • Decapinol Oral Rinse 2535
  • Regulatory Pathway: FDA 510(k) clearance as "oral rinse to reduce adhesion of dental plaque" (21 CFR 872.5580, Product Code: NTO), Class II devices with special controls 2535.

2. Mouthwashes Approved as Drugs (FDA NDA/ANDA Pathway)

Some mouthwashes, especially those with active pharmaceutical ingredients (APIs) like chlorhexidine gluconate or sodium fluoride, are regulated as drugs and require New Drug Applications (NDA) or Abbreviated New Drug Applications (ANDA).

A. Antimicrobial Mouthwashes (Chlorhexidine Gluconate)

  • Examples:
  • Regulatory Pathway: FDA NDA or ANDA approval. These are prescription (Rx) drugs. ANDA approvals require the generic product to be qualitatively and quantitatively (Q1/Q2) the same as the reference listed drug, and bioequivalence waivers are often granted due to the topical (oral cavity) use 224455606365667075.

B. Anticaries/Antiplaque/Antigingivitis Mouthwashes (Fluoride, Triclosan)

  • Examples:
    • Colgate Total (sodium fluoride 0.24%, triclosan 0.30%) 203848577173
  • Regulatory Pathway: FDA NDA approval (505(b)(1)), as these are considered new drugs due to their active ingredients and claims. The review includes efficacy and safety data for anti-caries and anti-gingivitis indications 203848577173.

3. EMA (European Medicines Agency) Approvals

  • The provided sources do not contain direct evidence of EMA approvals for mouthwashes. Some products are manufactured by European companies (e.g., Sinclair Pharmaceuticals, Bioplax Limited), but the regulatory pathway described is for FDA clearance, not EMA approval 18253552.
  • Note: In the EU, many mouthwashes are regulated as medical devices under the Medical Device Regulation (MDR) or as medicinal products, depending on their ingredients and claims. However, no EMA-specific approval data is present in the provided sources.

Summary Table

Type of MouthwashExample ProductsFDA Regulatory PathwayClass/Status
Dry Mouth/Artificial SalivaBiotene, Oral-B, SmartMouth, Oral7510(k)Unclassified/Class II
DesensitizingColgate Sensitive, Listerine Defense510(k)Class II
Oral Wound/MucositisAftamed, MuGard, OraMagic510(k)Unclassified/Class II
Plaque/Gingivitis (Non-drug)Decapinol510(k)Class II
Antimicrobial (Chlorhexidine)Peridex, ********NDA/ANDARx Drug
Anticaries/Antiplaque (Fluoride)Colgate TotalNDAOTC/Rx Drug

Key Points

  • Most dry mouth, desensitizing, and wound care mouthwashes are regulated as medical devices and cleared via the FDA 510(k) pathway.
  • Antimicrobial and anticaries mouthwashes with active drug ingredients (e.g., chlorhexidine, fluoride) are regulated as drugs and require NDA or ANDA approval.
  • Bioequivalence waivers are commonly granted for generic chlorhexidine gluconate rinses due to their topical use and identical formulation to reference products 224455606365667075.
  • No direct EMA approval data is present in the provided sources.

Leveraged by large pharma, independent consultants, and everyone in between

  • This could get very addicting... I would live in this.

    Director of Reg Affairs at top-20 Pharma
  • I want this. I'm really impressed by the quality of the information and the level of detail.

    Head of Combination Devices Reg Affairs
  • I spent two days with Rhizome and it was a firehose - manually, it would have taken a month.

    Director of Reg Affairs at top-5 Pharma
  • In regulatory work, speed is nice but accuracy is non-negotiable. I appreciate a tool that prioritizes getting it right.

    Principle Regulatory Affairs Consultant
  • This would make us so much better informed - we never have the time to do this research manually.

    Senior Director of Reg Affairs at Pharma Supplier

Simple pricing, for everyone.

Project

Immediate, flexible access

$400/mo

  • All of our FDA premarket, postmarket databases
  • All of our EMA datasets: EPARs, Guidelines, CTIS, etc.
  • Guidance, clinical trials, and SBOAs for 4 other regions
  • Pay with a credit card
Access

Professional

Best-value single-seat access

$3,500/yr

  • All of our FDA premarket, postmarket databases
  • All of our EMA datasets: EPARs, Guidelines, CTIS, etc.
  • Guidance, clinical trials, and SBOAs for 4 other regions
  • Pay with a credit card
Access

Business

Scale your research

$20,000/yr

  • Annual access for 5 seats
  • All of our professional-tier databases
  • Monthly office hours
  • Invoice-based pricing
Contact Us

Enterprise

Comprehensive global access

Custom

  • Annual access for 5 seats
  • All business-tier benefits
  • All regulatory, clinical DBs in South Korea, China, Japan
  • Biweekly office hours
Contact Us

With Rhizome, you'll always know the best path forward.